Longevity · Longevity peptide (research)
Humanin
- Drug class
- Longevity peptide (research)
- Status
- Compounded (503A)
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Humanin is studied for
- Neuroprotection (research)
- Cellular resilience (research)
- Metabolic support (research)
Mechanism of action
Humanin is being studied in the longevity category. Mitochondrial peptide studied for neuroprotection and cellular resilience. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Humanin?
Humanin is a longevity peptide. Mitochondrial peptide studied for neuroprotection and cellular resilience.
What is Humanin studied for?
Published research has examined Humanin for neuroprotection, cellular resilience, metabolic support. Human clinical evidence varies by indication.
Is Humanin FDA-approved?
No. Humanin is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Humanin used in research?
Protocols vary by study. Humanin is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Humanin is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
